Study of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue Sarcoma

NCT05858710 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Sarcoma, Soft Tissue

Interventions

DRUG: DPPG2-TSL-DOX
DRUG: Dexrazoxane

Sponsor

Thermosome GmbH